Their study concludes that elevated PHLDA1 expression is controlled through an ER-NF-κβ-miRNA-181 regulatory axis, which increases the stem-like BC phenotype, and thus alters the prognosis of BC patients [51]. The gene discussed is NFKB1; the disease is breast cancer.